v3.25.2
Share Options (Tables)
 6 Months Ended
Jun. 30, 2025
Share Options [Abstract]  
Schedule of Company’s Share Option Activity for Employees and Members of the Board of Directors

The following table presents the Company’s share option activity for employees and members of the Board of Directors of the Company under the Plan for the periods of three months ended June 30, 2025 and 2024:

 

   Number of
Share
Options		   Weighted
Average
Exercise
Price		   Weighted
average
remaining
contractual
life		   Intrinsic
value		 
       $   (years)   $ 
                 
Outstanding as of December 31, 2024   1,345,036    2.95    7.17    2,677 
Granted   161,000    2.87    -    - 
Exercised   (11,060)   1.77    -    - 
Cancelled   (53,200)   3.25    -    - 
Outstanding as of June 30, 2025 (unaudited)   1,441,776    2.94    7.14    1,125 
Exercisable as of June 30, 2025 (unaudited)   689,274    2.20    4.98    860 
   Number of
Share
Options		   Weighted
Average
Exercise
Price		   Weighted
average
remaining
contractual
life		   Intrinsic
value		 
       $   (years)   $ 
                 
Outstanding as of December 31, 2023   1,295,367    2.09    6.04    84 
Granted   48,600    4.32    -    - 
Exercised   (393,651)   1.99    -    - 
Cancelled   (7,500)   3.20    -    - 
Outstanding as of June 30, 2024 (unaudited)   942,816    2.24    6.71    2,811 
Exercisable as of June 30, 2024 (unaudited)   563,204    2.15    5.42    1,730 
Schedule of Ranges of Exercise Prices

The outstanding share options as of June 30, 2025 have been separated into ranges of exercise prices, as follows:

 

Exercise price  Share options
outstanding
as of
June 30,
2025		   Weighted
average
remaining
contractual
term		   Share options
exercisable
as of
June 30,
2025		   Weighted
average
remaining
contractual
term		 
   Unaudited 
       (years)       (years) 
                 
-
   17,680    1.70    17,680    1.70 
1.14   82,580    1.54    82,580    1.54 
1.48   50,000    8.21    21,875    8.21 
1.74   12,800    7.80    6,400    7.80 
1.83   556,714    6.07    443,476    5.74 
2.30   10,400    9.82    
-
    
-
 
2.40   10,000    9.82    
-
    
-
 
2.43   8,800    9.75    
-
    
-
 
2.79   6,400    8.09    2,800    8.09 
2.97   92,000    9.47    3,950    9.40 
2.98   99,400    9.99    
-
    
-
 
3.20   5,002    6.15    4,689    6.15 
3.59   28,800    9.24    
-
    
-
 
4.00   76,000    7.68    57,024    7.68 
4.96   315,200    9.07    1,300    9.07 
5.02   30,000    8.99    7,500    8.99 
5.12   40,000    0.55    40,000    0.55 
    1,441,776         689,274      
Schedule of Assumptions Used to Estimate the Fair Values of the Options Granted

The following table presents the assumptions used to estimate the fair values of the share options granted in the reported periods presented:

 

   Six-month period ended
June 30,		 
   2025   2024 
         
Volatility (%)   60.51%-61.52%    52.7%-73.5% 
Risk-free interest rate (%)   3.9%-4.5%    4.0%-4.3% 
Dividend yield (%)   
-
    
-
 
Expected life (years)   6.25    6.25 
Exercise price ($)   2.30-4.00    1.47-5.02 
Share price ($)   2.40-4.00    1.72-4.96 
Schedule of Total Compensation Cost

The total compensation cost related to all of the Company’s equity-based awards recognized in profit and loss during the periods of six months ended June 30, 2025 and 2024 was comprised as follows:

 

   Six-month period ended
June 30,		 
   2025   2024 
   Unaudited 
         
Research and development  $137   $126 
Sales and marketing   13    11 
General and administrative   177    48 
   $327   $185